Results 151 to 160 of about 43,487 (351)
Applications of chromatin immunoprecipitation-based epigenomic tools in nutritional studies [PDF]
, 2008 Jiejun Wu, Tim H-M. Huang
openalex +1 more source
CTCF binding site classes exhibit distinct evolutionary, genomic, epigenomic and transcriptomic features [PDF]
, 2009 Kobby Essien +5 more
openalex +1 more source
Identification of histone modifications in biomedical text for supporting epigenomic research [PDF]
, 2009 Corinna Kolářik +2 more
openalex +1 more source
Glia, EarlyView.Multiple sclerosis involves chronic CNS inflammation and neurodegeneration. This review highlights glial cells as key drivers in progressive MS, focusing on lesion pathology, molecular dysfunction, and human‐relevant model systems. ABSTRACT Multiple sclerosis (MS) is the most common non‐infectious inflammatory CNS disease, characterized by progressive ...
Volker Siffrin
wiley +1 more source
Epigenomic profiling indicates a role for DNA methylation in early postnatal liver development [PDF]
, 2009 Robert A. Waterland +12 more
openalex +1 more source
Immunity & AgeingSystemic lupus erythematosus (SLE) is an autoimmune disorder that commonly affects the skin, kidneys, joints, and various other systemic tissues, with its development intricately linked to the process of immunosenescence.
Feng Xiong +10 more
doaj +1 more source
A hitchhiker's guide to single‐cell epigenomics: Methods and applications for cancer research
International Journal of Cancer, EarlyView.Abstract Genetic mutations are well known to influence tumorigenesis, tumor progression, treatment response and relapse, but the role of epigenetic variation in cancer progression is still largely unexplored. The lack of epigenetic understanding in cancer evolution is in part due to the limited availability of methods to examine such a heterogeneous ...
Marta Moreno‐Gonzalez +2 more
wiley +1 more source
The X as Model for RNA's Niche in Epigenomic Regulation [PDF]
, 2010 J. T. Lee
openalex +1 more source
Epigenomics‐guided precision oncology: Chromatin variants in prostate tumor evolution
International Journal of Cancer, EarlyView.Abstract Prostate cancer is a common malignancy that in 5%–30% leads to treatment‐resistant and highly aggressive disease. Metastasis‐potential and treatment‐resistance is thought to rely on increased plasticity of the cancer cells—a mechanism whereby cancer cells alter their identity to adapt to changing environments or therapeutic pressures to create
Kira Furlano +6 more
wiley +1 more source
Epigenomic Modifications Predict Active Promoters and Gene Structure in Toxoplasma gondii
, 2007 Mathieu Gissot +4 more
openalex +2 more sources